Pay in 4 interest-free payments of $6.18 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
A typical stacked protocol looks like BPC-157 daily (usually 250500 mcg subcutaneous) plus TB-500 once or twice weekly (usually 25 mg subcutaneous) for 4 to 8 weeks
4-12 weeks 1 x 10 mL bottle 4 weeks: 2 vials use 4 mL total
Prescription Required This formulation must be prescribed by a licensed medical provider
Those considering BPC-157 should understand they are using an experimental compound with unknown long-term effects, sourced from an unregulated market where product quality and purity cannot be guaranteed
Conditions include alcoholic liver disease, viral hepatitis, cirrhosis, and primary or metastatic liver cancer Renal dysfunction : Impaired kidney function reduces B12 elimination, causing accumulation even with normal intake Haematological conditions : Myeloproliferative neoplasms, chronic myeloid leukaemia, polycythaemia vera, and hypereosinophilic syndrome increase transcobalamin production, elevating total serum B12 Laboratory interference : Macro-B12 (immunoglobulin-bound B12) and assay interference can cause spuriously elevated results without true excess In clinical practice, unexplained hypercobalaminaemia should prompt investigation for underlying disease, particularly in patients without obvious supplementation history
US$ 22.21
US$ 21.75
US$ 27.46
